-
Study: Amylin's metreleptin improves diabetes, lipid control among patients
SAN DIEGO — An investigational drug improved diabetes and lipid control in patients with partial lipodystrophy, according to a new study.
Amylin Pharmaceuticals announced Saturday results of a study of metreleptin, an analog of the human hormone leptin. Results of the study were presented at the 93rd annual meeting and expo of the Endocrine Society in Boston.
-
White House roundtable discussion: Health information technology can help curb Rx abuse
ALEXANDRIA, Va. — The White House on Friday held a roundtable discussion with approximately two dozen leaders across the public safety, healthcare and technology sectors to address how health information technology can help limit prescription drug abuse, the National Community Pharmacists Association noted in a release on Monday.
The main focus was how data from prescription drug monitoring programs can better facilitate prescribing, be incorporated into pharmacies and be leveraged in emergency rooms, the association stated.